SLC5A2 and diabetes mellitus: Pharmacological treatments for diabetes were as follows: three cases with insulin injections, seven cases with GLP-1 analog injections, seven cases with biguanides, ten with insulin secretagogue, eighteen with SGLT2 inhibitors, sixteen with DPP4 inhibitors, and three with thiazolidine, and three with imeglimin.